ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
19 announcements
Fairchem Organics shows a recovery in Q1 FY27, driven by higher price realizations and reduced Chinese dumping, though margins remain vulnerable to external geopolitical factors and raw material volatility.
Fairchem Organics reported strong Q1 FY27 results with revenue up 34.3% Y-o-Y to INR 1,761 Mn and EBITDA margins expanding to 10.16% driven by better domestic realization.
Fairchem Organics held its 7th Annual General Meeting on July 27, 2026. Shareholders considered various resolutions including dividend declaration and reappointment of directors.
Fairchem Organics Ltd reported revenue from operations of ₹176.1 Cr (+34.3% YoY) and net profit of ₹10 Cr (+733.3% YoY) for Q1 FY27.
Fairchem Organics Ltd will hold a board meeting on 27 July 2026 to approve its unaudited Q2 FY2026 results. Trading window stays closed until 29 July 2026.
Fairchem Organics' CARE Ratings reaffirmed its bank facilities of about ₹181.24 Crore, keeping an A; Stable rating. The facilities comprise ₹173.99 Cr long‑term, ₹2.25 Cr mixed, and ₹5 Cr short‑term.
Fairchem Organics submitted its FY 2025‑26 Business Responsibility and Sustainability Report per SEBI LODR rules. It reports CSR turnover of ₹459.65 Crore and key ESG disclosures.
Fairchem Organics Ltd will hold its AGM on July 27, 2026 to adopt audited results and declare a Rs.1 dividend. Three directors, including the MD, are re‑appointed.
Fairchem Organics filed its FY 2025‑26 annual report and issued the notice for the AGM on 27 July 2026. The filing satisfies SEBI LODR requirements.
Fairchem Organics Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms overall regulatory compliance with SEBI standards.
Fairchem Organics reported Q4 FY26 revenue of ₹117cr (-3.2% YoY) and PAT of ₹3.7cr. FY26 revenue was ₹460cr (-14.5% YoY) with PAT at ₹6.2cr.
Fairchem Organics faces a challenging FY26 with a 14.5% revenue decline, though margins improved in Q4 due to reduced Chinese dumping and energy efficiency gains.
Fairchem Organics reported a Q4 FY26 revenue of ₹1,169 Mn, down 3.2% Y-o-Y, with PAT at ₹37 Mn. FY26 annual revenue fell 14.5% to ₹4,596 Mn due to weak demand.
Fairchem Organics Limited recommended a final dividend of Rs. 1.00 (10%) per equity share for FY 2025-26. The record date is set for July 20, 2026, with the dividend payment scheduled to be completed by August 25, 2026, subject to shareholder approval at the upcoming AGM.
Fairchem Organics Limited has re-appointed Mr. Sudhin Choksey as an Independent Director for a second 60-month term. The reappointment is effective from February 11, 2027, through February 10, 2032, subject to shareholder approval at the company's 7th Annual General Meeting.
Fairchem Organics Ltd reported revenue from operations of ₹116.9 Cr (-3.2% YoY) and net profit of ₹3.7 Cr (+516.7% YoY) for Q4 FY26.
Fairchem Organics approved its FY26 audited results and recommended a 10% dividend (Rs. 1.00 per share). The board also re-appointed Sudhin Choksey as an Independent Director and scheduled the 7th AGM for July 27, 2026. July 20, 2026, is fixed as the record date for dividend eligibility.
Fairchem Organics Ltd has scheduled a board meeting for May 6, 2026, to approve audited financial results for the year ended March 31, 2026. The board will also consider recommending a dividend on equity shares. Consequently, the trading window for company securities remains closed until May 8, 2026.
Fairchem Organics Ltd submitted its quarterly confirmation certificate under Regulation 74(5) for the period ended March 31, 2026. The Registrar and Transfer Agent, MUFG Intime India, confirmed that all securities received for dematerialisation were processed within prescribed timelines. The company noted its entire share capital remains in dematerialized form.